Logo image of APLT

APPLIED THERAPEUTICS INC (APLT) Stock Fundamental Analysis

NASDAQ:APLT - US03828A1016 - Common Stock

0.512 USD
0 (-0.41%)
Last: 8/22/2025, 8:00:00 PM
0.512 USD
0 (0%)
After Hours: 8/22/2025, 8:00:00 PM
Fundamental Rating

2

Taking everything into account, APLT scores 2 out of 10 in our fundamental rating. APLT was compared to 549 industry peers in the Biotechnology industry. While APLT seems to be doing ok healthwise, there are quite some concerns on its profitability. APLT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

APLT had negative earnings in the past year.
In the past year APLT has reported a negative cash flow from operations.
In the past 5 years APLT always reported negative net income.
APLT had a negative operating cash flow in each of the past 5 years.
APLT Yearly Net Income VS EBIT VS OCF VS FCFAPLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

APLT has a Return On Assets of -76.46%. This is in the lower half of the industry: APLT underperforms 66.67% of its industry peers.
APLT has a Return On Equity (-118.66%) which is in line with its industry peers.
Industry RankSector Rank
ROA -76.46%
ROE -118.66%
ROIC N/A
ROA(3y)-185.04%
ROA(5y)-152.5%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
APLT Yearly ROA, ROE, ROICAPLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K -2K

1.3 Margins

APLT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
APLT Yearly Profit, Operating, Gross MarginsAPLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -5K -10K -15K -20K

More info and screens

5

2. Health

2.1 Basic Checks

APLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
APLT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, APLT has more shares outstanding
APLT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
APLT Yearly Shares OutstandingAPLT Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
APLT Yearly Total Debt VS Total AssetsAPLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

APLT has an Altman-Z score of -18.05. This is a bad value and indicates that APLT is not financially healthy and even has some risk of bankruptcy.
APLT's Altman-Z score of -18.05 is on the low side compared to the rest of the industry. APLT is outperformed by 82.51% of its industry peers.
There is no outstanding debt for APLT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -18.05
ROIC/WACCN/A
WACC9.76%
APLT Yearly LT Debt VS Equity VS FCFAPLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

APLT has a Current Ratio of 3.00. This indicates that APLT is financially healthy and has no problem in meeting its short term obligations.
APLT's Current ratio of 3.00 is on the low side compared to the rest of the industry. APLT is outperformed by 64.12% of its industry peers.
APLT has a Quick Ratio of 3.00. This indicates that APLT is financially healthy and has no problem in meeting its short term obligations.
With a Quick ratio value of 3.00, APLT is not doing good in the industry: 62.30% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 3
Quick Ratio 3
APLT Yearly Current Assets VS Current LiabilitesAPLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

APLT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.86%, which is quite impressive.
The Revenue for APLT has decreased by -97.39% in the past year. This is quite bad
EPS 1Y (TTM)84.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.61%
Revenue 1Y (TTM)-97.39%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

The Earnings Per Share is expected to grow by 15.16% on average over the next years. This is quite good.
Based on estimates for the next years, APLT will show a very strong growth in Revenue. The Revenue will grow by 226.65% on average per year.
EPS Next Y27.07%
EPS Next 2Y19%
EPS Next 3Y16.61%
EPS Next 5Y15.16%
Revenue Next Year315.91%
Revenue Next 2Y669.57%
Revenue Next 3Y406.87%
Revenue Next 5Y226.65%

3.3 Evolution

APLT Yearly Revenue VS EstimatesAPLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
APLT Yearly EPS VS EstimatesAPLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -1 -2 -3 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for APLT. In the last year negative earnings were reported.
Also next year APLT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
APLT Price Earnings VS Forward Price EarningsAPLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
APLT Per share dataAPLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

A more expensive valuation may be justified as APLT's earnings are expected to grow with 16.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19%
EPS Next 3Y16.61%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for APLT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

APPLIED THERAPEUTICS INC

NASDAQ:APLT (8/22/2025, 8:00:00 PM)

After market: 0.512 0 (0%)

0.512

0 (-0.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners81.67%
Inst Owner Change-16.95%
Ins Owners2.09%
Ins Owner Change12.74%
Market Cap73.73M
Analysts80
Price Target2.93 (472.27%)
Short Float %7.37%
Short Ratio5.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)152.44%
Min EPS beat(2)22.6%
Max EPS beat(2)282.27%
EPS beat(4)3
Avg EPS beat(4)54.75%
Min EPS beat(4)-197.84%
Max EPS beat(4)282.27%
EPS beat(8)3
Avg EPS beat(8)-31.7%
EPS beat(12)7
Avg EPS beat(12)-10.6%
EPS beat(16)10
Avg EPS beat(16)-5.63%
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)13.82%
EPS NY rev (1m)0%
EPS NY rev (3m)14.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-66.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-72.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 272.51
P/FCF N/A
P/OCF N/A
P/B 1.98
P/tB 1.98
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.47
Fwd EYN/A
FCF(TTM)-0.66
FCFYN/A
OCF(TTM)-0.66
OCFYN/A
SpS0
BVpS0.26
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -76.46%
ROE -118.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-185.04%
ROA(5y)-152.5%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3
Quick Ratio 3
Altman-Z -18.05
F-Score4
WACC9.76%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.61%
EPS Next Y27.07%
EPS Next 2Y19%
EPS Next 3Y16.61%
EPS Next 5Y15.16%
Revenue 1Y (TTM)-97.39%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year315.91%
Revenue Next 2Y669.57%
Revenue Next 3Y406.87%
Revenue Next 5Y226.65%
EBIT growth 1Y8.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year24.21%
EBIT Next 3Y26.24%
EBIT Next 5YN/A
FCF growth 1Y-54.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-54.99%
OCF growth 3YN/A
OCF growth 5YN/A